Resection rates for pancreatic cancer remain low in Europe and the US, even for patients with early-stage tumors.


By Reuters Staff

NEW YORK (Reuters Health) – The pancreatic cancer resectability criteria advocated by the National Comprehensive Cancer Network (NCCN) may be more complicated than necessary, Japanese researchers say.

Read More

By David Douglas

NEW YORK (Reuters Health) - In concert with the peptide iRGD, nanoparticles with hollow silica cores can enhance the delivery of irinotecan to a murine model of pancreatic ductal adenocarcinoma, according to California-based researchers.

Read More

The American Society of Clinical Oncology (ASCO) has updated their recommendations for adjuvant treatment of surgically resected pancreatic cancer, published in the Journal of Clinical Oncology (published online April 11, 2017; doi:10.1200/JCO.2017.72.4948).

Read More

Subscribe to Pancreatic Cancer